ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 53 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,345,874 | +14.0% | 1,770,090 | +32.1% | 0.00% | +33.3% |
| Q2 2023 | $6,445,968 | +245741.6% | 1,340,118 | +107.5% | 0.00% | +50.0% |
| Q1 2023 | $2,622 | -27.1% | 645,883 | -3.0% | 0.00% | 0.0% |
| Q4 2022 | $3,595 | -99.9% | 665,716 | +24.3% | 0.00% | -33.3% |
| Q3 2022 | $5,371,000 | +94.5% | 535,492 | -8.9% | 0.00% | +50.0% |
| Q2 2022 | $2,762,000 | +1000.4% | 587,583 | +1481.1% | 0.00% | – |
| Q4 2021 | $251,000 | – | 37,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $13,361,000 | 2.79% |
| GREAT POINT PARTNERS LLC | 928,282 | $3,630,000 | 0.88% |
| RA Capital Management | 9,770,773 | $38,204,000 | 0.83% |
| GUARDIAN POINT CAPITAL, LP | 500,000 | $1,955,000 | 0.71% |
| Deep Track Capital, LP | 2,599,098 | $10,162,000 | 0.65% |
| WMS Partners, LLC | 181,068 | $708,000 | 0.10% |
| Perceptive Advisors | 596,942 | $2,334,000 | 0.05% |
| BVF INC/IL | 289,663 | $1,133,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 358,482 | $1,402,000 | 0.04% |
| Woodline Partners LP | 501,236 | $1,960,000 | 0.03% |